Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Pediatric Neurology
|
August 29, 2017
Utility of the Autism Observation Scale for Infants in Early Identification of Autism in Tuberous Sclerosis Complex
Jamie K Capal, Paul S Horn, Donna S Murray, et al.
The American Psychologist
|
April 5, 2019
Impacting development in infants with tuberous sclerosis complex: Multidisciplinary research collaboration
Marian E Williams, Deborah A Pearson, Jamie K Capal, et al.
Nature Reviews. Drug Discovery
|
May 18, 2021
Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunities
Michelle L Krishnan, Elizabeth Berry-Kravis, Jamie K Capal, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
July 15, 2018
Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience
Darcy A Krueger, Jamie K Capal, Paolo Curatolo, et al.
BMC Medicine
|
August 8, 2023
Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM
Annelieke R Müller, Michiel A J Luijten, Lotte Haverman, et al.
BMC Medicine
|
October 23, 2023
Correction: Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM
Annelieke R Müller, Michiel A J Luijten, Lotte Haverman, et al.
Annals of the Child Neurology Society
|
December 27, 2024
Preventative treatment of tuberous sclerosis complex with sirolimus: Phase I safety and efficacy results
Jamie K Capal, David M Ritter, David Neal Franz, et al.
Molecular Cancer Research : MCR
|
July 16, 2017
Tuberin Regulates Prostaglandin Receptor-Mediated Viability, via Rheb, in mTORC1-Hyperactive Cells
Chenggang Li, Xiaolei Liu, Yang Liu, et al.
Frontiers in Psychiatry
|
March 17, 2022
Empowering Families Through Technology: A Mobile-Health Project to Reduce the TAND Identification and Treatment Gap (TANDem)
Tosca-Marie Heunis, Stacey Bissell, Anna W Byars, et al.
Journal of Neurodevelopmental Disorders
|
September 14, 2023
International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)
Petrus J de Vries, Tosca-Marie Heunis, Stephanie Vanclooster, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Pediatric Neurology
|
August 29, 2017
Utility of the Autism Observation Scale for Infants in Early Identification of Autism in Tuberous Sclerosis Complex
Jamie K Capal, Paul S Horn, Donna S Murray, et al.
The American Psychologist
|
April 5, 2019
Impacting development in infants with tuberous sclerosis complex: Multidisciplinary research collaboration
Marian E Williams, Deborah A Pearson, Jamie K Capal, et al.
Nature Reviews. Drug Discovery
|
May 18, 2021
Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunities
Michelle L Krishnan, Elizabeth Berry-Kravis, Jamie K Capal, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
July 15, 2018
Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience
Darcy A Krueger, Jamie K Capal, Paolo Curatolo, et al.
BMC Medicine
|
August 8, 2023
Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM
Annelieke R Müller, Michiel A J Luijten, Lotte Haverman, et al.
BMC Medicine
|
October 23, 2023
Correction: Understanding the impact of tuberous sclerosis complex: development and validation of the TSC-PROM
Annelieke R Müller, Michiel A J Luijten, Lotte Haverman, et al.
Annals of the Child Neurology Society
|
December 27, 2024
Preventative treatment of tuberous sclerosis complex with sirolimus: Phase I safety and efficacy results
Jamie K Capal, David M Ritter, David Neal Franz, et al.
Molecular Cancer Research : MCR
|
July 16, 2017
Tuberin Regulates Prostaglandin Receptor-Mediated Viability, via Rheb, in mTORC1-Hyperactive Cells
Chenggang Li, Xiaolei Liu, Yang Liu, et al.
Frontiers in Psychiatry
|
March 17, 2022
Empowering Families Through Technology: A Mobile-Health Project to Reduce the TAND Identification and Treatment Gap (TANDem)
Tosca-Marie Heunis, Stacey Bissell, Anna W Byars, et al.
Journal of Neurodevelopmental Disorders
|
September 14, 2023
International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)
Petrus J de Vries, Tosca-Marie Heunis, Stephanie Vanclooster, et al.
Page
of 4